Ignite Creation Date:
2024-05-06 @ 8:38 AM
Last Modification Date:
2024-10-26 @ 12:03 PM
Study NCT ID:
NCT02785653
Status:
COMPLETED
Last Update Posted:
2016-06-09
First Post:
2016-05-25
Brief Title:
Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium
Sponsor:
Maharashtra University of Health Sciences
Organization:
Maharashtra University of Health Sciences
Study Overview
Official Title:
Effect of Sevoflurane on the Onset Characteristics and Intubating Conditions of Rocuronium Under Routine Clinical Practice
Status:
COMPLETED
Status Verified Date:
2016-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SRI
Brief Summary:
This study evaluates the potentiation of muscle relaxation caused by rocuronium by inhalational agent sevoflurane Half the patients will be ventilated with oxygen nitrous oxide and sevoflurane during induction of anaesthesia and half will be ventilated only with oxygen and nitrous oxide
Detailed Description:
Rocuronium is a non depolarizing muscle relaxant Inhalational general anaesthetic agents like Sevoflurane have some muscle relaxation effect by depressing the spinal motor neurons Inhalational anaesthetics also alter the tonic input received from descending modulatory systems from the brain Deep anaesthesia with inhalational agents may cause some degree of neuromuscular blockade
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None